Published in:
Open Access
01-10-2012 | Contrast Media
MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation
Authors:
C. S. van Kessel, W. B. Veldhuis, M. A. A. J. van den Bosch, M. S. van Leeuwen
Published in:
European Radiology
|
Issue 10/2012
Login to get access
Abstract
Objectives
To assess whether, in patients with normal liver function, a hepatobiliary delay time of 10 min after Gd-EOB-DTPA injection is sufficient for lesion characterisation.
Methods
In 42 consecutive patients with suspected focal liver lesions, dynamic MRI was performed after intravenous Gd-EOB-DTPA, followed by hepatobiliary phases at 5, 10 and 20 min. The following items were assessed at each hepatobiliary phase: parenchymal enhancement, contrast agent excretion in bile ducts, lesion enhancement characteristics (hypo-, iso-, or hyperintensity, rim enhancement, central non-enhancement), and contrast- and signal-to-noise ratios, separately for hypo- and hyperintense lesions.
Results
Following enhancement, parenchymal signal intensity increased significantly up to 10 min (86.3%, P < 0.001), and subsequently stabilised (86.5% after 20 min, P = 0.223). Biliary contrast agent excretion was first observed in 2, 32 and 5 patients after 5, 10 and 20 min respectively. Hepatobiliary lesion enhancement characteristics observed after 5 min persisted during later hepatobiliary phases. CNR and SNR ratios increased significantly (P < 0.05) up to 10 min after enhancement without further increase at 20 min, in hypo- and hyperintense lesions.
Conclusions
If lesion characterisation is the primary reason for performing MRI, a hepatobiliary delay time of 10 min after Gd-EOB-DTPA injection is sufficient in patients with normal liver function.
Key Points
• Magnetic resonance imaging is now a first line of investigation of the liver.
• Optimal CNR and SNR are achieved 10 min after Gd-EOB-DTPA injection.
• Typical enhancement characteristics are observed early and do not change.
• Ten-minute hepatobiliary delay is sufficient for characterisation of focal liver lesions.